≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Hypertrophy of (infrapatellar) fat pad

DOID EFO MESH PheWeb

M13_FATPADHYPERTROPHY

muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 M79.4
Hospital discharge: ICD-9 7293A
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 M79.4
Cause of death: ICD-9 7293A
Cause of death: ICD-8 $!$

270

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

270

diagram downward connector

Check minimum number of events None

270

diagram downward connector

Include endpoints None

270

diagram downward connector
M13_FATPADHYPERTROPHY

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2
Parent code in ICD-10 M79
Name in latin Hypertrophia corporis adiposi infrapatellaris

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 270 172 98
Unadjusted prevalence (%) 0.08 0.09 0.06
Mean age at first event (years) 38.38 37.92 39.20

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.01 0.71 [0.28, 1.75] 4.5e-1 13
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: M13_FATPADHYPERTROPHY – Hypertrophy of (infrapatellar) fat pad
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Hypertrophy of (infrapatellar) fat pad
after Hypertrophy of (infrapatellar) fat pad

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Hypertrophy of (infrapatellar) fat pad

↥